Recce Pharmaceuticals (ASX:RCE) targeting antibiotic-resistant bacteria
14 Jun 2018 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham talks about the company's lead product RECCE 327 for use in targeting antibiotic-resistant bacteria, its US FDA approval pathway and a Phase 1 clinical trial.